Copyright
©The Author(s) 2023.
World J Gastrointest Surg. Feb 27, 2023; 15(2): 258-272
Published online Feb 27, 2023. doi: 10.4240/wjgs.v15.i2.258
Published online Feb 27, 2023. doi: 10.4240/wjgs.v15.i2.258
Table 3 Meta-regression analysis for comparison of subgroups
Subgroup | β | SE | 95%CI | Z value | P value | |
Lower limit | Upper limit | |||||
1-yr DFS | ||||||
Intercept | 0.658 | 0.177 | 0.311 | 1.005 | 3.720 | < 0.001 |
LT vs RH | 0.9301 | 0.283 | 0.376 | 1.485 | 3.290 | 0.001 |
RFA vs RH | -0.315 | 0.272 | -0.848 | 0.217 | -1.160 | 0.246 |
TACE vs RH | -1.823 | 0.447 | -2.699 | -0.946 | -4.080 | < 0.001 |
3-yr DFS | ||||||
Intercept | -0.353 | 0.212 | -0.769 | 0.063 | -1.660 | 0.096 |
RFA vs RH | -0.609 | 0.335 | -1.266 | 0.049 | -1.810 | 0.070 |
TACE vs RH | -2.235 | 0.751 | -3.707 | -0.763 | -2.980 | 0.003 |
LT vs RH | 1.1811 | 0.322 | 0.550 | 1.812 | 3.670 | < 0.001 |
5-yr DFS | ||||||
Intercept | -0.748 | 0.216 | -1.171 | -0.325 | -3.460 | 0.001 |
RFA vs RH | -0.834 | 0.366 | -1.552 | -0.116 | -2.280 | 0.023 |
TACE vs RH | -0.762 | 0.577 | -1.893 | 0.369 | -1.320 | 0.186 |
LT vs RH | 1.2581 | 0.324 | 0.623 | 1.893 | 3.880 | < 0.001 |
1-yr OS | ||||||
Intercept | 2.185 | 0.208 | 1.777 | 2.594 | 10.480 | < 0.001 |
LT vs RH | -0.0361 | 0.332 | -0.687 | 0.614 | -0.110 | 0.913 |
RFA vs RH | -0.041 | 0.325 | -0.677 | 0.596 | -0.130 | 0.900 |
TACE vs RH | -0.614 | 0.332 | -1.264 | 0.036 | -1.850 | 0.064 |
3-yr OS | ||||||
Intercept | 0.996 | 0.162 | 0.679 | 1.313 | 6.150 | < 0.001 |
RFA vs RH | -0.394 | 0.251 | -0.885 | 0.098 | -1.570 | 0.116 |
TACE vs RH | -1.114 | 0.287 | -1.676 | -0.551 | -3.880 | < 0.001 |
LT vs RH | 0.0401 | 0.265 | -0.479 | 0.558 | 0.150 | 0.881 |
5-yr OS | ||||||
Intercept | 0.204 | 0.185 | -0.158 | 0.565 | 1.100 | 0.270 |
RFA vs RH | -0.317 | 0.293 | -0.890 | 0.257 | -1.080 | 0.279 |
TACE vs RH | -0.917 | 0.328 | -1.559 | -0.275 | -2.800 | 0.005 |
LT vs RH | 0.3921 | 0.298 | -0.192 | 0.975 | 1.320 | 0.188 |
- Citation: Chen JL, Chen YS, Ker CG. Network meta-analysis of the prognosis of curative treatment strategies for recurrent hepatocellular carcinoma after hepatectomy. World J Gastrointest Surg 2023; 15(2): 258-272
- URL: https://www.wjgnet.com/1948-9366/full/v15/i2/258.htm
- DOI: https://dx.doi.org/10.4240/wjgs.v15.i2.258